Cutibacterium acnes strain and its medical use

Selected Cutibacterium acnes strains and their derivatives address the limitations of current anti-inflammatory treatments by promoting fibroblast proliferation and inhibiting pathogens, effectively treating skin and mucous membrane conditions without side effects or resistance.

JP2026094271APending Publication Date: 2026-06-09EILEENS PHARMA SOCIETA A RESPONSABILITA LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
EILEENS PHARMA SOCIETA A RESPONSABILITA LTD
Filing Date
2026-02-26
Publication Date
2026-06-09

AI Technical Summary

Technical Problem

Current anti-inflammatory treatments for skin and mucous membrane conditions often cause side effects and contribute to antibiotic resistance, necessitating the development of novel products with anti-inflammatory and potentially antibacterial activity without significant side effects.

Method used

Utilization of selected Cutibacterium acnes strains, their cell wall fragments, or postbiotics, which promote fibroblast proliferation and inhibit pathogenic bacteria and fungi, modulating the immune system and providing immunomodulatory effects.

Benefits of technology

The strains and their derivatives effectively treat skin and mucous membrane infections, reduce inflammation, and normalize the commensal microbiome, while avoiding side effects and antibiotic resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026094271000012
    Figure 2026094271000012
  • Figure 2026094271000013
    Figure 2026094271000013
  • Figure 2026094271000014
    Figure 2026094271000014
Patent Text Reader

Abstract

The present invention provides for the use of pharmaceutical or nutritional compositions for the prevention or treatment of inflammatory diseases such as dermatitis or psoriasis or infections, particularly fungal or bacterial infections of the skin or mucous membranes. [Solution] The present invention relates to selected Cutibacterium acnes strains and / or their cell walls or postbiotics of the strains, and their medical or nutritional uses. The present invention also relates to pharmaceutical or nutritional compositions containing strains, their cell walls or postbiotics for the prevention or treatment of inflammatory diseases such as dermatitis or psoriasis or infections, particularly fungal or bacterial infections of the skin or mucous membranes.
Need to check novelty before this filing date? Find Prior Art